As omens go, epilepsy medtech Epiminder’s ASX debut on Monday, perhaps the stock exchange’s outage to start December wasn’t the best of signs. A technical glitch meant price-sensitive announcements couldn’t be published for several hours and 50 ASX-listed companies were forced into trading halts. Epiminder’s (ASX: EPI) initial public offering (IPO) at $1.50 per share… Read more »
Voluntary administration has not dampened the ambitions of medical device startup Seer Medical, which is seeking a buyer as it prepares to release the next generation of its epilepsy home monitoring and detection device in the United States. Administrator Lindsay Bainbridge of Pitcher Partners Melbourne said non-binding offers are being sought for Seer Medical for… Read more »
Melbourne-based epilepsy monitoring startup Epi-Minder has raised $16 million bridge financing round. The raise was backed by existing shareholders including Cochlear, the Bionics Institute, the University of Melbourne and Seer Medical, as well as private investors. The venture plans to use the cash to expand clinical trials for epilepsy monitoring device, Minder, as well as… Read more »
Daily startup news and insights, delivered to your inbox.
